Aster DM Healthcare Limited has informed the Exchange about Transcript

Aster DM Healthcare reported Q1 FY26 revenue of INR 1,078 crores, up 8% year-on-year, with operating EBITDA growing 21% to INR 215 crores and margins expanding 230 basis points to 20% from 17.7%. Normalized profit after tax rose 22% to INR 90 crores. Average revenue per occupied bed (ARPOB) crossed INR 50,000 for the first time, up 14% YoY, driven by a shift toward higher-value specialties like oncology (now 11% of revenue). The company has 5,197 beds currently and plans to add 2,600 more, including 1,439 beds in Bangalore via a new 500-bed hospital in Yeswanthpur. The proposed merger with Blackstone-backed QCIL is progressing, with shareholder and CCI approvals secured, creating a combined platform of 10,350 beds across 38 hospitals that delivered proforma revenue of INR 2,157 crores (12% growth) in Q1. Management guided for mid-teen revenue growth over a 3-4 year horizon, with 7-8% from volumes and 7-8% from ARPOB, and expects continued margin expansion.